[The use of sulprostone for voluntary interruption of gestation and in intrauterine fetal death].
The paper attempts to assess the efficacy of Sulprostone as a preoperative dilator of the uterine cervix in the +VIG operations performed both before and after the 90th day of amenorrhea and in cases of intrauterine fetal death. From January to September 1987, 271 cases of VIG before the 90th day of amenorrhea, 2 cases of VIG after the 90th day of amenorrhea, and 3 cases of intrauterine fetal death were operated at Vercelli Midwifery School. Sulprostone, a synthetic prostaglandin, was shown to be a valuable aid on the basis of the results obtained and the slight side effects observed.
Di Meglio
L
L
Scuola Autonoma di Ostetricia e Ginecologia, Ospedale Generale Provinciale Sant'Andrea di Vercelli.
Malagnino
F
F
Ballerini
M
M
Mocchia
M
M
D000019:Abortifacient Agents; D000020:Abortifacient Agents, Nonsteroidal; D000028:Abortion, Induced; D015232:Dinoprostone / Q000031:analogs & derivatives*; D004341:Drug Evaluation; D005260:Female; D005313:Fetal Death; D006801:Humans; D011247:Pregnancy
D000019:Abortifacient Agents; D000020:Abortifacient Agents, Nonsteroidal; C016767:sulprostone; D015232:Dinoprostone
Sull'impiego del Sulprostone nella IVG e nella morte endouterina del feto.